943609-66-3
943609-66-3
Chemical Structure
Vedolizumab
Synonym(s): Anti-Human lymphocyte α4β7 integrin, Humanized Antibody; LDP-02; MLN-002
- CAS No.: 943609-66-3
- Formula:N/A
- Molecular Weight:(146.868 kDa)
SMILES: [Vedolizumab]
Biological Activity: Vedolizumab is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Vedolizumab | 99.90% | Vedolizumab is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Vedolizumab (anti-α4β7-integrin) | 99.90% | Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
